Incidence of postnatal HIV transmission after an initial negative HEID PCR among HIV-exposed infants in Tanzania: a cohort study

In the landscape of global health, few challenges are as urgent or as personal as preventing a mother from passing the human immunodeficiency virus to her child. For decades, medical science has made tremendous strides in stopping this transmission during pregnancy and childbirth. When a pregnant woman takes specific medicines to suppress the virus, the chance of the baby being born with the infection drops to nearly zero. However, the story does not end at birth. In many parts of the world, including Tanzania, mothers continue to breastfeed their infants for months or even years. During this extended period of breastfeeding, the virus can still find a way to cross from mother to child, a risk that becomes the primary source of new infections once the dangers of pregnancy and delivery have been largely tamed.

To protect these infants, health systems rely on a process called early infant diagnosis. This involves taking a small blood sample from a baby, usually around six weeks of age, to test for the virus. If the test is negative, it means the baby was not infected at birth. But a negative result at six weeks is not a permanent guarantee. The baby remains vulnerable as long as breastfeeding continues, and the mother's health can change. The critical question for public health officials is: once a baby tests negative in those early weeks, how likely is it that they will become infected later while still being breastfed? Until now, answering this question with real data from Tanzania has been difficult because tracking mothers and babies over such a long period is complex, and many families simply stop coming to the clinic for follow-up tests.

A team of researchers set out to fill this gap by looking at a massive collection of records from Tanzania's national health laboratories. They focused on a specific group of mothers and babies: those where the baby had already tested negative for the virus in the first two months of life. The researchers wanted to see what happened next. They linked the baby's test results with the mother's viral load data, which is a measurement of how much virus is circulating in her blood. The logic is straightforward: if a mother has a high amount of virus in her system, the risk of passing it to her baby through breast milk is higher. By connecting these two pieces of information, the team hoped to measure the rate of new infections and understand how the mother's health status influenced the baby's safety.

The study began with a vast pool of more than 98,000 babies who had tested negative in their first eight weeks. However, the researchers quickly encountered a significant hurdle. In a system designed to track health over time, only a tiny fraction of these families, about 1.6 percent, had returned for the necessary follow-up testing that would show if the baby remained healthy or had become infected later. The vast majority of the records ended after that first negative test, leaving a large hole in the data. This missing information is not just a statistical inconvenience; it reflects a real-world challenge where families are lost to the health system, or where testing happens in clinics that do not share their data with the central national database. Despite this limitation, the researchers were able to analyze the 1,583 mother-baby pairs who did have follow-up records, providing a rare glimpse into what happens after the initial diagnosis.

What they found was both reassuring and concerning. Among the babies who were followed, the risk of catching the virus after a clean start was real. Over the course of the study period, which tracked these infants up to about 40 weeks of age, the researchers identified 20 new infections. When they calculated the rate of these infections relative to the amount of time the babies were being observed, it came to roughly 2.24 new cases for every 100 babies followed for a full year. By the time the babies reached 40 weeks, the cumulative risk of infection had risen to just over 2 percent. This means that even with a negative test in the first two months, a small but significant number of babies still acquired the virus while breastfeeding.

The data painted a clear picture of why these infections were happening. The risk was not spread evenly; it depended heavily on the mother's viral load. For mothers whose virus was completely undetectable in their blood, the risk to the baby was very low, with an infection rate of about 1.25 per 100 babies per year. However, as the amount of virus in the mother's blood increased, the danger to the baby rose sharply. For mothers with a high level of virus, specifically 1,000 copies or more per milliliter of blood, the infection rate jumped to more than 7 per 100 babies per year. This pattern confirmed a biological truth: the more virus a mother has, the more likely she is to pass it to her child, even when the child has already been born healthy. The study also noted that many of these new infections occurred later in the breastfeeding period, between 24 and 40 weeks, suggesting that the risk accumulates over time as the mother and baby continue their daily contact.

The researchers also uncovered a troubling disconnect in how the health system monitors these families. They found that for nearly 80 percent of the mothers in their study, the last time their viral load was checked was more than six weeks after the baby was born. This timing is a missed opportunity. The period immediately after birth and during the early weeks of breastfeeding is when the risk of transmission is highest, yet the health system often fails to check the mother's status during this critical window. If a mother's virus becomes active or her medication stops working during these early weeks, the system might not know until months later, by which time the baby may have already been infected.

Perhaps the most striking finding of the study was not just the rate of infection, but the sheer scale of the missing data. The fact that only 1.6 percent of eligible babies had a follow-up test in the central records suggests that the current system is blind to the vast majority of these families. The researchers suspect this is due to a combination of factors: many families simply do not return for testing, and many tests are now done at local clinics using portable machines that do not automatically send their results to the national database. This creates a fragmented view of the epidemic, where the national numbers look better than they might actually be because the most vulnerable or hardest-to-reach families are not being counted.

The study concludes that while medical treatments have successfully reduced the risk of infection at birth, the battle is not won until breastfeeding ends. The data shows that postnatal transmission remains a measurable threat, driven largely by mothers who have high levels of virus in their blood. To truly eliminate the transmission of HIV to children, the researchers argue that the health system must do more than just test babies once. It needs to build a continuous, unified tracking system that follows every mother and child from pregnancy through the end of breastfeeding. This system must be able to connect the results from large central laboratories with those from small, local clinics, ensuring that no mother's viral load goes unchecked and no baby's follow-up test is missed. Without closing these gaps in surveillance and care, the goal of ending pediatric HIV will remain out of reach, no matter how effective the medicines themselves may be.